We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Heptares and Takeda Initiate Drug Discovery Collaboration Focused on GPCR Linked to CNS Disorders

News   Apr 18, 2011

 
Heptares and Takeda Initiate Drug Discovery Collaboration Focused on GPCR Linked to CNS Disorders
 
 
 

RELATED ARTICLES

A Milestone Is Reached For New Leukemia Drug

News

Cold Spring Harbor Laboratory scientists, with chemists and cancer biologists from Dana-Farber Cancer Institute (DFCI), have developed a new therapy that extended the survival of mice with acute myeloid leukemia.

READ MORE

New Database Could Help Identify Therapeutic Targets for the Creation of Antibiotics

News

Researchers have created a database called "BacFITBase" which characterizes bacterial genes relevant to the infection process in live organisms. The new database aims to aid the discovery of novel therapeutic targets for the creation of antibiotics.

READ MORE

Antibody Has the Ability To Halt Progression of Pulmonary Arterial Hypertension

News

Scientists have identified a novel antibody that has the potential to become a new treatment for pulmonary arterial hypertension (PAH). The antibody was found to stop the progress of the disease in rodent and cell models, and reverse the proliferation of cells which cause the arteries to thicken.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE